About the Company
Headquartered in Irvine, California, Edwards Lifesciences Corporation is a medical technology company. It has over 13,900 employees that work in over 40 operations across the world. Some of the countries it operates in include Mexico, Ireland, Greece, Korea, Canada, Japan, India, Colombia, Portugal, Sweden, Italy, etc. This company is a global leader in the field of cardiac valves and hemodynamic monitoring.
The company offers therapies, speciality teams and medical devices to its customer from around the world. It offers therapies of seven types, including clot management, hypotension management, Aortic Stenosis, shock management, enhanced surgical recovery and blood conservation. It has speciality teams under five categories, including, Surgical Team, TAVI Heart team, Anaesthesia, Hospital Administration and Critical Care team.
Edwards also offers an array of medical devices under nine different categories namely vascular catheters, pressure monitoring, surgical valve replacement, hemodynamic monitoring, transcatheter heart valves, devices support software, pressure monitoring, transcatheter valve repair, accessories & instruments and surgical valve repair. Its most renowned product is the SAPIEN transcatheter aortic valve that is developed with the help of cow tissues.
As of 2020, it is an S&P 500 component that has been recognised by prestigious organisations like Forbes and Fortune. It is the 613th company in the 2020 Fortune 1000 list and 1006th company in the 2020 Forbes Global 2000 list. Forbes has also recognized Edwards in its 2021 list of Just Companies. It trades in the New York Stock Exchange under the ticker symbol EW since 2000. The advent of Edwards Lifesciences dates back to 1958 when Miles Lowell Edwards was building the first artificial heart. He was in his 60s and had just retired from engineering with about 63 patents from several sectors under him. His knack towards healing a sick heart developed due to his own childhood experience with heart issues. He presented his concept of mechanising heart to an Oregon Medical School doctor name Dr Albert Starr. Soon Edwards Laboratories was established, and later got acquired by American Hospital Supply Corporation, changing its name to American Edwards Laboratories.
In 1985, Baxter acquired American Edwards and spun it off as an independent publicly-held company in 2000, as Edwards Lifesciences. Between 2017 and 2019, the company has acquired Valtech Cardio at $340 million, Harpoon Medical at $100 million and CAS Medical Systems at approximately $100 million. To make any investment, one must be aware of company details they are investing in.;
|Organisation||Edwards Lifesciences Corp|